“Explosive Growth Potential”: 2 Under-The-Radar Cancer Drugmakers For Risk-Tolerant Investors

Which developmental-stage biotechs have the potential to beat the difficult odds and successfully get their novel drugs to market? The author of today’s article highlights two under-the-radar cancer drugmakers with such potential – and which therefore might appeal to risk-tolerant investors looking for explosive growth potential. For these two stocks – one of which might even have a megablockbuster product on its hands – CLICK HERE.